Sequential Administration of FE75C and Docetaxel Versus Docetaxel/Cyclophosphamide in HER-2 Negative, Node Positive Breast Cancer
Clinical trial NCT01985724 · COMPLETED
Trial details
- NCT number
- NCT01985724
- Sponsor
- Hellenic Oncology Research Group
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-10-01
- Primary completion
- 2013-12-01
- Enrollment
- 650
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.